Author

Edyta Korbut

HYDROGEN SULFIDE SIGNALING IN GERD-INDUCED MTOR-DEPENDENT PALIGENOSIS: IMPLICATION FOR BARRETT'S ESOPHAGUS PATHOGENESIS
HYDROGEN SULFIDE SIGNALING IN GERD-INDUCED MTOR-DEPENDENT PALIGENOSIS: IMPLICATION FOR BARRETT'S ESOPHAGUS PATHOGENESIS

Edyta Korbut  et al.

CONTRIBUTION OF HYDROGEN SULFIDE-PRODUCING CYSTATHIONINE-G-LYASE (CTH) IN THE DEVELOPMENT OF BARRETT'S METAPLASIA-SPECIFIC MOLECULAR PROFILE AND SYSTEMIC INFLAMMATION
CONTRIBUTION OF HYDROGEN SULFIDE-PRODUCING CYSTATHIONINE-G-LYASE (CTH) IN THE DEVELOPMENT OF BARRETT'S METAPLASIA-SPECIFIC MOLECULAR PROFILE AND SYSTEMIC INFLAMMATION

Edyta Korbut  et al.

INHIBITORY EFFECT OF PHARMACOLOGICALLY-DERIVED OR ENDOGENOUSLY PRODUCED HYDROGEN SULFIDE (H2S) ON THE DEVELOPMENT OF BARRETT’S METAPLASIA THROUGH IL-1BETA/COX-2/PGE2 PATHWAY LOOP
INHIBITORY EFFECT OF PHARMACOLOGICALLY-DERIVED OR ENDOGENOUSLY PRODUCED HYDROGEN SULFIDE (H2S) ON THE DEVELOPMENT OF BARRETT’S METAPLASIA THROUGH IL-1BETA/COX-2/PGE2 PATHWAY LOOP

INHIBITORY EFFECT OF SLOW H2S-RELEASING DONOR (GYY4137) ON THE DEVELOPMENT OF BARRETT’S METAPLASIA-SPECIFIC MOLECULAR PROFILE AND INFLAMMATORY SIGNALING
INHIBITORY EFFECT OF SLOW H2S-RELEASING DONOR (GYY4137) ON THE DEVELOPMENT OF BARRETT’S METAPLASIA-SPECIFIC MOLECULAR PROFILE AND INFLAMMATORY SIGNALING

Edyta Korbut  et al.

INHIBITORY EFFECT OF PHARMACOLOGICALLY-DERIVED OR ENDOGENOUSLY PRODUCED HYDROGEN SULFIDE (H2S) ON THE DEVELOPMENT OF BARRETT’S METAPLASIA THROUGH IL-1BETA/COX-2/PGE2 PATHWAY LOOP
INHIBITORY EFFECT OF PHARMACOLOGICALLY-DERIVED OR ENDOGENOUSLY PRODUCED HYDROGEN SULFIDE (H2S) ON THE DEVELOPMENT OF BARRETT’S METAPLASIA THROUGH IL-1BETA/COX-2/PGE2 PATHWAY LOOP

Edyta Korbut  et al.

CONTRIBUTION OF ENZYMATIC ACTIVITY OF HEME OXYGENASE (HMOX) AND ITS BYPRODUCT, CARBON MONOXIDE (CO) IN BARRETT'S METAPLASIA DEVELOPMENT
CONTRIBUTION OF ENZYMATIC ACTIVITY OF HEME OXYGENASE (HMOX) AND ITS BYPRODUCT, CARBON MONOXIDE (CO) IN BARRETT'S METAPLASIA DEVELOPMENT

Edyta Korbut  et al.

HYDROGEN SULFIDE (H2S)-RELEASING AP-39 MODULATES GASTRIC MUCOSAL MITOCHONDRIAL ACTIVITY PREVENTING THE OXIDATIVE ISCHEMIA/REPERFUSION (I/R)-INDUCED GASTRIC MUCOSAL INJURY
HYDROGEN SULFIDE (H2S)-RELEASING AP-39 MODULATES GASTRIC MUCOSAL MITOCHONDRIAL ACTIVITY PREVENTING THE OXIDATIVE ISCHEMIA/REPERFUSION (I/R)-INDUCED GASTRIC MUCOSAL INJURY

Edyta Korbut  et al.

MITOCHONDRIA-TARGETED DELIVERY OF HYDROGEN SULFIDE (H2S)-PRODRUG COUNTERACTS GASTROTOXICITY OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS. INVOLVEMENT OF HEME OXYGENASE PATHWAY
MITOCHONDRIA-TARGETED DELIVERY OF HYDROGEN SULFIDE (H2S)-PRODRUG COUNTERACTS GASTROTOXICITY OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS. INVOLVEMENT OF HEME OXYGENASE PATHWAY

Edyta Korbut  et al.

MITOCHONDRIA-TARGETING HYDROGEN SULFIDE-RELEASING AP-39 IN PREVENTION OF CHEMICALLY-INDUCED GASTRIC MUCOSAL DAMAGE
MITOCHONDRIA-TARGETING HYDROGEN SULFIDE-RELEASING AP-39 IN PREVENTION OF CHEMICALLY-INDUCED GASTRIC MUCOSAL DAMAGE

Edyta Korbut  et al.

NOVEL METAL-FREE CARBON MONOXIDE-RELEASING PRODRUG IN PREVENTION OF GASTRIC MUCOSA AGAINST NSAIDS-INDUCED GASTROTOXICITY
NOVEL METAL-FREE CARBON MONOXIDE-RELEASING PRODRUG IN PREVENTION OF GASTRIC MUCOSA AGAINST NSAIDS-INDUCED GASTROTOXICITY

Edyta Korbut  et al.

Item 1 - 10 / 10
1